Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Normal human lung fibroblasts differently modulate interleukin-10 and interleukin-12 production by monocytes: implications for an altered immune response in pulmonary chronic inflammation.
Vancheri C, Mastruzzo C, Tomaselli V, Sortino MA, D'Amico L, Bellistrí G, Pistorio MP, Salinaro ET, Palermo F, Mistretta A, Crimi N. Vancheri C, et al. Am J Respir Cell Mol Biol. 2001 Nov;25(5):592-9. doi: 10.1165/ajrcmb.25.5.4609. Am J Respir Cell Mol Biol. 2001. PMID: 11713101
Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings.
Abate F, Di Biasio F, Marchese R, Markushi TB, Ciammola A, Ticozzi N, Calandra-Buonaura G, Cani I, Sambati L, Fabbrini G, Costanzo M, Soricelli A, Frosini D, Del Prete E, Schirinzi T, Stefani A, Borroni B, Padovani A, Barone P, Picillo M, Pilotto A; PSP-NET study group. Abate F, et al. Parkinsonism Relat Disord. 2024 Dec 10;131:107226. doi: 10.1016/j.parkreldis.2024.107226. Online ahead of print. Parkinsonism Relat Disord. 2024. PMID: 39700727
A phase II open label, randomized clinical trial of atezolizumab with or without human recombinant IL-7 (CYT107) in advanced urothelial cancer.
Sweis RF, Chatta GS, Jain RK, Moon H, Delacroix SE, Fang A, D'Amico L, Kask AS, Cheever MA, Fling S, Sharon E, Lacroix A, Kaiser JC, Pachynski RK, Yu EY. Sweis RF, et al. Among authors: d amico l. Clin Cancer Res. 2024 Nov 22. doi: 10.1158/1078-0432.CCR-24-1728. Online ahead of print. Clin Cancer Res. 2024. PMID: 39576210
A promising eco-sustainable wound dressing based on cellulose extracted from Spartium junceum L. and impregnated with Glycyrrhiza glabra L extract: Design, production and biological properties.
Sallustio V, Rossi M, Mandrone M, Rossi F, Chiocchio I, Cerchiara T, Longo E, Fratini M, D'Amico L, Tromba G, Malucelli E, Protti M, Mercolini L, Di Blasio A, Aponte M, Blaiotta G, Abruzzo A, Bigucci F, Luppi B, Cappadone C. Sallustio V, et al. Among authors: d amico l. Int J Biol Macromol. 2024 Jun;272(Pt 2):132883. doi: 10.1016/j.ijbiomac.2024.132883. Epub 2024 Jun 3. Int J Biol Macromol. 2024. PMID: 38838898 Free article.
Effect of Lactobacillus reuteri NCIMB 30351 drops on symptoms of infantile functional gastrointestinal disorders and gut microbiota in early infants: Results from a randomized, placebo-controlled clinical trial.
Tyrsin OY, Tyrsin DY, Nemenov DG, Ruzov AS, Odintsova VE, Koshechkin SI, D Amico L. Tyrsin OY, et al. Among authors: d amico l. Eur J Pediatr. 2024 May;183(5):2311-2324. doi: 10.1007/s00431-024-05473-y. Epub 2024 Mar 1. Eur J Pediatr. 2024. PMID: 38427038 Clinical Trial.
110 results